Edition:
India

Nabriva Therapeutics PLC (NBRV.OQ)

NBRV.OQ on NASDAQ Stock Exchange Global Select Market

5.18USD
18 Apr 2018
Change (% chg)

$-0.09 (-1.71%)
Prev Close
$5.27
Open
$5.25
Day's High
$5.37
Day's Low
$5.14
Volume
43,038
Avg. Vol
49,358
52-wk High
$14.09
52-wk Low
$4.39

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 1.12 -0.584
Sep '17 1.47 -0.791
Jun '17 1.05 -0.537
Mar '17 1.68 -5.596
FY 2016 Dec '16
Sep '16 0.97 -0.658
Jun '16 1.78 -0.570
Mar '16 1.42 -6.421
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 5 1.24 1.80 1.00 --
Quarter Ending Sep-18 5 1.10 1.90 0.50 --
Year Ending Dec-18 6 4.90 7.40 3.00 5.92
Year Ending Dec-19 7 16.14 22.90 8.82 23.19
Earnings (per share)
Quarter Ending Jun-18 5 -0.56 -0.42 -0.74 --
Quarter Ending Sep-18 5 -0.54 -0.37 -0.75 --
Year Ending Dec-18 6 -2.18 -1.65 -2.85 -2.30
Year Ending Dec-19 7 -1.99 -1.05 -3.20 -13.74
LT Growth Rate (%) 2 25.75 97.20 -45.70 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % 72.07 -- --
EPS (TTM) % -7.80 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Nabriva Therapeutics PLC

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -5.25 -8.52 24 --
13 Week -20.95 -24.80 19 --
26 Week -24.27 -30.03 25 --
52 Week 15.92 -1.75 60 --
YTD 39.26 22.30 69 --
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 78.47%
# of Holders: 54
Total Shares Held: 28,810,277
3 Mo. Net Change: 3,411,734
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 4
# Reduced Positions: 1
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.